Complex regional pain syndrome
Drug research and approvals for complex regional pain syndrome: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 33 studies of complex regional pain syndrome are recruiting on ClinicalTrials.gov, Health Canada has authorized 3 drug trials for it since 2013, and FDA has 0 approved and 14 open orphan designations naming it.
- Recruiting worldwide: 33
- Trials authorized in Canada: 3
- FDA orphan approvals: 0
- EU medicines: 0
- Phase 3, Open-Label Extension Study of AMBTX-01 (Neridronate) for Complex Regional Pain Syndrome Type 1NCT07857733 · Phase 3 · Ambros Therapeutics, Inc. · starts Oct 13, 2026
- Graded Motor Imagery Effects on Body Perception Disturbance in Complex Regional Pain Syndrome : a Randomised Controlled…NCT07818174 · Not applicable · Nantes University Hospital · starts Nov 16, 2026
- CRPS-RISE Outcomes RegistryNCT07811362 · Not reported · Ambros Therapeutics, Inc. · starts Oct 17, 2026
- ESWT for CRPS-I After Distal Radius FractureNCT07807852 · Not applicable · Dilek ün oguzhanasilturk · starts Jun 26, 2026
- Effects of Non-invasive Brain Stimulation on Pain Avoidance Behavior in Chronic Pain PatientsNCT07791966 · Not applicable · The Cleveland Clinic · starts Oct 1, 2026
- How the Brain and Body Recover After a Wrist FractureNCT07777081 · Not reported · Cambridge University Hospitals NHS Foundation Trust · starts Aug 12, 2026
- CRPS-Hand: Contrast + Compression vs WhirlpoolNCT07744269 · Not applicable · Ankara Etlik City Hospital · starts May 1, 2026
- Prospective Case Series Evaluating 6-Month and 12-Month Outcomes After Cryoneurolysis for Chronic PainNCT07639060 · Not reported · Yale University · starts Jun 20, 2026
- Empowered Relief for CaregiversNCT07636980 · Not applicable · Stanford University · starts Oct 1, 2026
How its trials ended
171 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 38 whose ending is known, 18% met their primary endpoint, 5% missed it and 76% stopped early.
- Completed, result not reported6437%
- Ongoing4627%
- Status unknown2313%
- Stopped: other or unclear138%
- Stopped: enrollment or feasibility106%
- Met its primary endpoint74%
- Stopped: sponsor or business decision42%
- Missed its primary endpoint21%
- Stopped: lack of efficacy11%
- Stopped: funding11%
| Apr 29, 2021 | Peripheral nerve injections for the treatment of upper extremity complex regional pain syndrome: a feasibility study for randomized placebo-controlled trialTriamcinolone | Ottawa Hospital Research Institute | Ongoing |
| Oct 16, 2019 | An open-label trial assessing the optimal dose efficacy and safety of GBM-5 in the treatment of pain associated with complex regional pain syndromeGBM-5 (morphine-bupivacaine-ketamine-naloxone-clonidine) / GBC-01… | Gilbert Blaise Inc | Pending |
| Jul 13, 2018 | Placebo-controlled efficacy and safety trial of intravenous neridronic acid in subjects with complex regional pain syndrome (CRPS)Neridronic acid | Grunenthal GmbH | Ongoing |
| Jan 23, 2026 | PsilocybinTreatment of complex regional pain syndrome | Cy Biopharma AG | Designated |
| Nov 20, 2024 | AfatinibTreatment of complex regional pain syndrome | Akigai As | Designated |
| Nov 20, 2024 | High cannabidiol botanical extractTreatment of complex regional pain syndrome | Biopharmaceutical Research Company, LLC | Designated |
| Jun 6, 2022 | KetamineTreatment of Complex Regional Pain Syndrome | Vitalis Analgesics, LLC | Designated |
| Oct 12, 2021 | KetamineTreatment of Complex Regional Pain Syndrome (CRPS) | PharmaTher Inc. | Designated |
| Jun 14, 2021 | NaltrexoneTreatment of Complex Regional Pain Syndrome | Soin Theraputics | Designated |
| May 10, 2021 | KetamineTreatment of Complex Regional Pain Syndrome | iX Biopharma Ltd. | Designated |
| Feb 1, 2019 | KetamineTreatment of Complex Regional Pain Syndrome | Bexson Biomedical, Inc. | Designated |
| Mar 7, 2018 | Delta-9-tetrahydrocannabinol and cannabidiolTreatment of complex regional pain syndrome | PhytoPain Pharma Inc. | Designated |
| Jun 16, 2016 | Hydromorphone hydrochloride (intrathecal infusion)Treatment of complex regional pain syndrome | Piramal Critical Care, Inc. | Designated |
| Oct 28, 2015 | BaclofenTreatment of complex regional pain syndrome | Piramal Critical Care, Inc. | Designated |
| Apr 15, 2015 | Zoledronate D,L-lysine monohydrate (ZLM)Treatment of complex regional pain syndrome (CRPS) | Thar Pharma, LLC | Designated |
| May 6, 2013 | Zoledronic acidTreatment of complex regional pain syndrome | Axsome Therapeutics, Inc. | Designated |
| Mar 25, 2013 | NeridronateTreatment of complex regional pain syndrome (CRPS-1, CRPS-II, CRPS-NOS) | Ambros Therapeutics, Inc. | Designated |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA